The company announces plans to reduce activities not critical to its development pipeline of drug candidates as part of its enhanced focus on clinical stage projects, it lays off 60 jobs and replaces the CEO, Christine Lind, with acting CEO Uli Hacksell. Medivir will notify the Public Employment Office of potential employee redundancies impacting approximately … Continue reading Medivir cuts 60 jobs and replaces its CEO